Physiology and management: Comparison of tilmicosin and cephapirin as therapeutics for Staphylococcus aureus mastitis at dry-off

Journal of Dairy Science

Volumn 82, Issue 4, 1999, Pages 696-703

  Nickerson, S C ^a   Owens, W E ^a   Fox, L K ^b   Scheifinger, C C ^c   Shryock, T R ^c   Spike, T E ^c  

^a LOUISIANA STATE UNIVERSITY AGRICULTURAL CENTER   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

^c ELANCO ANIMAL HEALTH   (United States)

Author keywords

Antibiotic; Mastitis; Staphylococcus aureus; Tilmicosin

Indexed keywords

STAPHYLOCOCCUS AUREUS;

ANTIINFECTIVE AGENT; CEFAPIRIN; CEPHALOSPORIN DERIVATIVE; DRUG DERIVATIVE; DRUG RESIDUE; MACROLIDE; TILMICOSIN; TYLOSIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; CATTLE; CATTLE DISEASE; CELL COUNT; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; FEMALE; LACTATION; MICROBIOLOGY; MILK; STAPHYLOCOCCUS INFECTION; SUBCUTANEOUS DRUG ADMINISTRATION; UDDER;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CELL COUNT; CEPHALOSPORINS; CEPHAPIRIN; DRUG RESIDUES; FEMALE; INJECTIONS, SUBCUTANEOUS; LACTATION; MACROLIDES; MAMMARY GLANDS, ANIMAL; MASTITIS, BOVINE; MILK; STAPHYLOCOCCAL INFECTIONS; TYLOSIN;

EID: 0033111345     PISSN: 00220302     EISSN: None     Source Type: Journal    
DOI: 10.3168/jds.S0022-0302(99)75286-0     Document Type: Article

References (24)

1. Clegg, F. G., G. J. Halliday, and H. Hardie. 1975. Dry cow therapy: a comparative field trial using benzathine cloxacillin and erythromycin. Br. Vet. J. 131:639-642.
2. Craven, N., and J. C. Anderson. 1979. The location of Staph. aureus in experimental chronic mastitis in the mouse and the effect on the action of sodium cloxacillin. Br. J. Exp. Pathol. 60: 453-459.
3. Cummins, K. A, and T. A. McCaskey. 1987. Multiple infusions of cloxacillin for treatment of mastitis during the dry period. J. Dairy Sci. 70:2658-2665.
4. Erskine, R. J., P. C. Bartlett, P. C. Crawshaw, and D. M. Gombas. 1994. Efficacy of intramuscular oxytetracycline as a dry cow treatment for Staphylococcus aureus mastitis. J. Dairy Sci. 77:3347-3353.
5. Harmon, R. J., R. J. Eberhart, D. E. Jasper, B. E. Langlois, and B. A. Wilson. 1990. Pages 1-13 in Microbiological Procedures for the Diagnosis of Bovine Udder Infection. 3rd ed. Natl. Mastitis Counc., Inc., Arlington, VA.
6. Helton-Groce, S. L., T. D. Thompson, and R. S. Readnour. 1993. A study of tilmicosin residues in milk following subcutaneous administration to lactating cows. Can. Vet. J. 34:619-621.
7. Hill, G. N., and T. J. Keefe. 1974. Clinical efficacy of benzathine cloxacillin in dry cow mastitis treatment. Mod. Vet. Pract. 55: 843-846.
8. Neave, F. K., F. H. Dodd, and E. Henriques. 1950. Udder infections in the dry period. J. Dairy Res. 17:37-49.
9. Neave, F. K., F. H. Dodd, and R. G. Kingwill. 1966. A method of controlling udder disease. Vet. Rec. 78:521-523.
10. Nickerson, S. C. 1991. Mastitis control in heifers and dry cows. Dairy Food Environ. Sanit. 11:438-443.
11. Oliver, J., F. K. Neave, and M. E. Sharpe. 1962. The prevention of infection of the dry udder. J. Dairy Res. 29:95-100.
12. Owens, W. E. 1987. Isolation of Staphylococcus aureus L forms from experimentally induced bovine mastitis. J. Clin. Microbiol. 25:1956-1961.
13. Owens, W. E., and J. L. Watts. 1987. Effect of milk on activity of antimicrobic against Staphylococcus aureus isolated from bovine udders. J. Dairy Sci. 70:1946-1951.
14. Owens, W. E., J. L. Watts, R. L. Boddie, and S. C. Nickerson. 1988. Antibiotic treatment of mastitis: comparison of intramammary and intramammary plus intramuscular therapies. J. Dairy Sci. 71:3143-3147.
15. Postle, D. S., and R. P Natzke. 1974. Efficacy of antibiotic treatment in the bovine udder as determined from field studies. Vet. Med. Small Anim. Clin. 69:1535-1539.
16. Schukken, Y. H., B. A. Mallard, J.C.M. Dekkers, K. E. Leslie, and M. J. Stear. 1994. Genetic impact on the risk of intramammary infection following Staphylococcus aureus challenge. J. Dairy Sci. 77:639-647.
17. Schultze, W. D., and H. D. Mercer. 1976. Nonlactating cow therapy with formulation of penicillin and novobiocin: therapeutic and prophylactic effects. Am. J. Vet. Res. 37:1275-1281.
18. Smith, A., D. R. Westgarth, M. R. Jones, F. K. Neave, and F. H. Dodd. 1967. Methods of reducing the incidence of udder infection in dry cows. Vet. Rec. 81:504-510.
19. Soback, S., G. Ziv, M. Winkler, and A. Saran. 1990. Systemic dry cow therapy - a preliminary report. J. Dairy Sci. 73: 661-666.
20. Sol, J., O. C. Sampimon, J. J. Snoep, and Y. H. Schukken. 1994. Factors associated with bacteriological cure after dry cow treatment of subclinical staphylococcal mastitis with antibiotics. J. Dairy Sci. 77:75-79.
21. Uvarov, O., J. M. Evans, M. Marshall, and D. Sizer. 1967. Dry cow therapy. Vet. Rec. 81:241-242.
22. Ziv, G. 1978. Principal Pharmacokinetics Aspects of Mastitis Therapy. Beecham Lab. Monogr., Beecham Inc., Bristol, TN.
23. Ziv, G., M. Shem-Tov, A. Glickman, M. Winkler, and A. Saran. 1995. Tilmicosin antibacterial activity and pharmacokinetics in cows. J. Vet. Pharmacol. Ther. 18:340-345.
24. Ziv, G., M. Storper, and A. Saran. 1981. Comparative efficacy of three antibiotic products for the treatment and prevention of subclinical mastitis during the dry period. Vet. Q. 3:74-77.